Clinical Trials on SARS-CoV2 Antibodies in Japan
Total 20 results
-
AstraZenecaActive, not recruitingCOVID-19, SARS-CoV-2Japan
-
Rohto Pharmaceutical Co., Ltd.CompletedSARS-CoV-2 Infection( COVID-19 )Japan
-
AstraZenecaTerminatedPrevention of Infectious Disease Caused by SARS-CoV-2Japan
-
AstraZenecaCompletedPrevention of Infectious Disease Caused by SARS-CoV-2Japan
-
PfizerActive, not recruitingCOVID-19 | SARS-CoV-2Japan
-
PfizerCompletedSARS-CoV-2 InfectionJapan
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionJapan
-
Ono Pharmaceutical Co. LtdCompletedSARS-CoV-2 Infection (COVID-19)Japan
-
Rohto Pharmaceutical Co., Ltd.CompletedSevere Acute Respiratory Syndrome Coronavirus 2Japan
-
MedicagoMitsubishi Tanabe Pharma CorporationTerminated
-
TakedaCompletedPrevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)Japan
-
National Defense Medical College, JapanCompleted
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaboratorsCompletedCOVID-19 | COVID | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)Spain, United States, Denmark, United Kingdom, Greece, Japan, Nigeria
-
AstraZenecaRecruiting
-
Atea Pharmaceuticals, Inc.Active, not recruitingCOVID-19 | SARS CoV 2 InfectionUnited States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
-
ShionogiNational Institute of Allergy and Infectious Diseases (NIAID)CompletedA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)SARS-CoV-2 InfectionUnited States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
-
ShionogiRecruitingSARS-CoV-2 InfectionJapan, United States